Share Name Share Symbol Market Type Share ISIN Share Description
The Mission Marketing Group LSE:TMMG London Ordinary Share GB00B11FD453 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 44.50p 43.00p 46.00p 45.00p 44.50p 44.50p 24,123 14:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 144.1 5.9 5.4 8.3 37.11

Mission Marketing Group Share Discussion Threads

Showing 1176 to 1199 of 1200 messages
Chat Pages: 48  47  46  45  44  43  42  41  40  39  38  37  Older
DateSubjectAuthorDiscuss
07/2/2018
10:47
solid buys coming in today. high StockRank on stockopedia.
mfhmfh
26/1/2018
12:00
Thanks RS. The article isn’t particularly insightful but he has a point on the trades, just 10 so far today. It’s been a long term hold for me, sold some a while back around the 44mark high I hope to regret one day. Just always overlooked for reasons I don’t really understand.
dr biotech
26/1/2018
11:53
Trading in 2017 is in line with market expectations. Revenues up 6% (4% organic) - sounds pretty good, in a year where there's been a lot of macro uncertainty (often marketing budgets are the first thing that companies cut). Headline PBT up 10% to £7.7m Net debt £7.5m, materially better than forecast. Lower net debt has triggered a reduction of 0.5% in the bank's interest rate. Trying to improve margins further - target is 14% by March 2020 (headline operating profit margin). That all sounds rather encouraging to me. Valuation - this looks cheap, even after allowing for the net debt, and some deferred consideration creditors. Note that the "Price to Tang.(ible) Book (value) above says "n/a". That means that P/TBV is negative. So that's a quick check to flag up that you need to check out the balance sheet. I don't like it - the group has a weak balance sheet, stuffed full of intangibles. There again, that's reflected in a very low PER. Stockopedia likes it! This is a very high StockRank; My opinion - obviously I like it, as I hold some. However, the only reason I still hold it is because my broker tried to sell them a while back (I wanted the money for something else), but there were no buyers. So beware that this share is extremely illiquid, and once you've bought, it can be almost impossible to sell. Or you would have to take a haircut anyway. Mind you, that lack of liquidity works nicely on the upside when good news comes out. I see that earlier today the market spread was 46p bid, 48p offer, and someone had to pay 1p premium price, at 49p, to get hold of just 6,000 shares! That said, I've just noticed that there were loads of trades today, totalling 650k shares. That's very, very unusual, as normally hardly anything trades in this share. So maybe I could have sold today, as there was plenty of demand. Of course, now the company has put out a decent trading update, I don't want to sell any more. Conclusion - it's cheap, but very illiquid normally, so tricky to get in & out of. Therefore, it's more a share for longer-term investors than traders.
mfhmfh
26/1/2018
10:55
Mfhmfh Can you post the article or the summary? In return see below high quality journalism and research from Motley Fool www.fool.co.uk/investing/2018/01/25/should-i-bet-on-these-2-value-stocks-for-2018/
red_shed2000
26/1/2018
08:22
Generally positive write up yesterday from Paul Scott
mfhmfh
25/1/2018
16:04
meanwhile, 500k reported shares traded but the spread gets wider. Asagi (long TMMG)
asagi
25/1/2018
15:33
Well same comment from me, different year (but same share price!) "These are stupidly undervalued"!
red_shed2000
25/1/2018
13:50
lol, only just, despite the age difference the gap is closing!!
pj 1
25/1/2018
13:04
Beat you to it PJ :-)
glasshalfull
25/1/2018
12:57
....... and reducing net debt.....
pj 1
25/1/2018
12:57
oh...& net debt coming in £4m lower than £11.5m forecast at under £7.5m. I’m sure it’ll break through 50p in 2018 Well done to all at Mission Marketing! Kind regards, GHF
glasshalfull
25/1/2018
12:55
:-) Enough said. 7 years consistent earnings growth. Kind regards, GHF
glasshalfull
25/1/2018
11:14
Edison update:- http://www.edisoninvestmentresearch.com/research/report/the-mission-marketing-group211060/full/#js
jeff h
25/1/2018
09:49
very positive trading update IMHO.
mfhmfh
25/1/2018
08:31
trading update is here: hTTps://www.investegate.co.uk/mission-marketing--tmmg-/rns/trading-statement/201801250700038502C/ reads well. Asagi (long TMMG)
asagi
23/1/2018
12:06
trading update surely must be coming soon. last year was on 19th January.
mfhmfh
10/1/2018
10:35
Many thanks GHF, it is the sort of commentary that makes these boards worth reading! Thought it worth adding that M & C Saatchi has moved from under 300p to touch 400p, all time high, since October. Sector should do well as the global economy picks up.
bbluesky
10/1/2018
09:31
Its certainly an enigma share not helped by the media sector generally being out of favour. Having said that its baffling why it isn't valued at least around 60p
pj 1
10/1/2018
09:16
GHF, thanks. Can't really argue with that! I've been in here for what feels like an eternity and have never sold a share. In fact every time we have the rise then inevitable fall I add at circa 40-41p. This is now a disproportionately high percentage of my portfolio (I'm sure peanuts in monetary terms compared to most, but significant to me) and it will remain that way whist the statements and results continue as they have for the last few years. GLA
red_shed2000
10/1/2018
08:57
TMMG Like many investors I’ve reviewed my holdings & watchlist during the last fortnight. I topped up and added substantially in relation to a few (such as CROS, OPM & PTY) which appeared undervalued - IMHO - in relation to prospects. Another on my list was an old favourite, The Mission Marketing (TMMG), a marketing communications & advertising company. This company has been in & out of my portfolio during the last few years. Last invested here in early 2016. TMMG’s profitability had recovered during recent years after running into difficulties & ramp up of debt suffered in the wake of the 2008/09 financial crisis. The FY09 results highlighted that net debt had ballooned to £20m & David Morgan was parachuted in as CEO as debt was restructured. Since 2014 the shares have been rangebound between 35p-50p with few exceptions. They are currently 43p mid-price having yet again failed to break the 50p ceiling. They have been on a high single digit PER for as long as I can remember. I feel that this may be about to change. “Why now?”... I here you ask. Well, the market have given this company a wide berth over the last few years. However - you knew there was to be a further however - their performance over the last 7 years belies this weak share price IMHO. They have delivered consistent earnings growth over the period, with exception of 2013 (nil growth) while introducing a progressive dividend policy in 2013. Earnings Record - year end Dec 2010A EPS 3.5p 2011A EPS 4.2p (+22% EPS growth) 2012A EPS 4.5p (+7% EPS growth) 2013A EPS 4.5p (nil growth) / Div 1p 2014A EPS 5.1p (+15% EPS growth) / Div 1.1p 2015A EPS 5.9p (+15% EPS growth) / Div 1.2p 2016A EPS 6.4p (+9% EPS growth) / Div 1.5p Forecasts 2017E EPS 7p (+11% EPS growth) / est. Div 1.7p (yield 4%) 2018E EPS 7.8p (+12% EPS growth) / est. Div 1.8p (yield 4.2%) 2019E EPS 8.8p (+13% EPS growth) / est. Div 2.0p (yield 4.7%) A credible record due in part to the long term relationships they have established with an exceptional blue chip client base. Presentation link below highlights (on p6) the fact that Aviva, BP & Bellway have been clients for over 20 years! Recent client wins, per their interim statement, include Mars, Neff, Reckitt Benckiser, Revlon, The Royal Mint and Universal Studios. As mentioned this strong client retention means they have better revenue visibility than many peers with 57% of their revenues delivered from clients of 5 years standing or more. The company have also grown to encompass 14 agencies across the globe. TMMG have quietly flown under the radar despite forecasts of double digit CAGR during the next 3 years. They also introduced a dividend in 2013, and as observed, the yield is forecast to have crept up to 4% for 2017. Meanwhile, net debt has reduced from £20m in 2018 to £11m today. Should be noted that once net debt reduced to c.£10m they undertook a few small bolt on acquisitions over the last couple of years. Importantly, free cashflow & margins are also expected to improve during the next few years. In 2016 FCF was £4.5m for a yield of 13.3% and in 2017 forecast to be £4.2m for yield of 12.3%. With investment made in recent years its is forecast to substantially improve in 2018 & 2019 to 17.6% & 19.5% respectively. PBT margins are also forecast to increase from 10.7% in 2016 to 12.6% in 2019. It should be noted that the company have a large H2 weighting - as anyone who reviews their interim statements will have observed over the years. This may be one reason for the low rating, as we all know that statement implying a H2 weighting may be perceived as a pending profit warning in many cases. Interim presentation here HTTP://www.themission.co.uk/media/1196/mission_interim_powerpoint_2017_v1.pdf So, in summary, the share price has gone nowhere for the last 3 years, while earnings have returned low double digit growth. I believe that if TMMG continue to deliver as per forecast, then it would not surprise me to see them break out from 35p-50p range before too long. Is it speculative to consider that they could double from the current share price price (43p) over the course of the next 18/24 months???... and while one is waiting there is a 4% dividend yield on offer that rises to 4.7% by 2019. Even if the share price doubled, on 7.8p forecast earnings in 2018 & 8.8p EPS in 2019, they would only be on a PER 10 - 11, which is hardly a racy multiple. Stock - o - pedia appear to agree, with TMMG on a Stock Rank rating of 91 & Magic Formula score A+ Disclosure I’ve been buying over recent sessions so as always, please consider my musings with a large pinch of salt and DYOR. This is not a full write-up but simply a short synopsis. Kind regards, GHF
glasshalfull
06/12/2017
11:19
Don't agree about the director selling. Of more interest is the institutional buying that went with it, a big positive. Share price imo at stale bulls point, price driven down on no news and very little volume and an excellent long term buying opportunity.
bbluesky
05/12/2017
20:24
I sold 30% at 42. Hopefully I’ll come to regret that, but the director sell was right at the peak. That still has a lot of influence on the current share price IMO.
dr biotech
05/12/2017
10:43
Well against my better judgement I have topped up today. I am so over weight here it's untrue but I really don't understand why the share price hasn't moved for 3 years despite ever increasing profits and cash flow. One day they will either fly or be taken over. I just repeat the same phrase here month after month - the market can remain irrational longer than I can remain rational....
red_shed2000
16/11/2017
17:12
Back to the standard trading range...
dr biotech
Chat Pages: 48  47  46  45  44  43  42  41  40  39  38  37  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180224 23:59:10